NCT06803524View on ClinicalTrials.gov

10-year Follow-up After a Single Dose Acellular Pertussis Vaccination

PHASE4RecruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Pertussis
Interventions
BIOLOGICAL

Pertagen® vaccine

Pertagen® vaccine, manufactured by BioNet-Asia Co., Ltd., Bangkok, Thailand. The vaccine is presented in pre-filled syringe, each containing one human dose (0.5 mL) of aP vaccine.

BIOLOGICAL

Adacel® vaccine

Adacel® vaccine, manufactured by Sanofi Pasteur, Ltd, Toronto, Ontario, Canada. The vaccine is presented in a single-dose vial, each containing one human dose (0.5 mL) of Tdap vaccine.

Trial Locations (2)

10400

RECRUITING

Vaccine Trial Centre, Ratchathewi

10700

RECRUITING

Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi

All Listed Sponsors
collaborator

BioNet-Asia Co., Ltd.

INDUSTRY

lead

Mahidol University

OTHER